Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

196
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Sales26 43126 50523 00624 51325 17625 852
Operating income (EBITDA)9 4158 8838 0457 7197 8978 280
Operating profit (EBIT)8 3308 0156 5946 4256 6247 272
Pre-Tax Profit (EBT)6 6926 6472 9684 4704 7594 837
Net income4 5655 6282 7563 4503 4763 493
EPS (PNC)91,511156,778,473,279,3
Dividend per Share (PNC)74,078,080,080,680,181,3
Yield4,71%4,97%5,10%5,13%5,10%5,18%
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Finances - Leverage
Actuals in M GBP Estimates in M GBP
Fiscal Period December 201220132014201520162017
Debt14 03712 64514 37713 07212 89712 273
Finance------
Operating income (EBITDA)9 4158 8838 0457 7197 8978 280
Leverage
(Debt/EBITDA)
1,49x1,42x1,79x1,69x1,63x1,48x
Capital Expenditure1 0511 1881 1882 1771 4641 578
Book Value Per Share (BVPS)120 PNC146 PNC87,6 PNC121 PNC73,7 PNC105 PNC
Cash Flow per Share87,7 PNC149 PNC108 PNC105 PNC207 PNC232 PNC
Announcement Date02/06/2013
12:01pm
02/05/2014
12:00pm
02/04/2015
03:18pm
---
Balance Sheet Analysis
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 76 354 M GBP -
Entreprise Value (EV) 89 426 M GBP 89 251 M GBP
Valuation 2015e 2016e
PER (Price / EPS) 20,0x 21,5x
Capitalization / Revenue 3,11x 3,03x
EV / Revenue 3,65x 3,55x
EV / EBITDA 11,6x 11,3x
Yield (DPS / Price) 5,13% 5,10%
Price to book (Price / BVPS) 13,0x 21,3x
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 26,2% 26,3%
operating Leverage (Delta EBIT / Delta Sales) - 1,15x
Net Margin (Net Profit / Revenue) 14,1% 13,8%
ROA (Net Profit / Asset) 7,23% 8,77%
ROE (Net Profit / Equities) 63,1% 87,6%
Rate of Dividend 103% 109%
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   8,88% 5,82%
Cash Flow / Sales (Taux d'autofinancement) 20,8% 40,0%
Capital Intensity (Assets / Sales) 1,95x 1,57x
Financial Leverage (Net Debt / EBITDA) 1,69x 1,63x
Price Earning Ratio
EPS & Dividend
Dynamic quotes  
ON
| OFF